BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33455353)

  • 21. Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.
    Rahimkhoei V; Alzaidy AH; Abed MJ; Rashki S; Salavati-Niasari M
    Adv Colloid Interface Sci; 2024 Jul; 329():103204. PubMed ID: 38797070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-Dimensional Nanomaterials for Photothermal Therapy.
    Liu S; Pan X; Liu H
    Angew Chem Int Ed Engl; 2020 Apr; 59(15):5890-5900. PubMed ID: 32017308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2D Hetero-Nanoconstructs of Black Phosphorus for Breast Cancer Theragnosis: Technological Advancements.
    Soman S; Kulkarni S; Pandey A; Dhas N; Subramanian S; Mukherjee A; Mutalik S
    Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional two-dimensional nanocomposites for photothermal-based combined cancer therapy.
    Wang X; Cheng L
    Nanoscale; 2019 Aug; 11(34):15685-15708. PubMed ID: 31355405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luminescent lanthanide nanomaterials: an emerging tool for theranostic applications.
    Ranjan S; Jayakumar MK; Zhang Y
    Nanomedicine (Lond); 2015 May; 10(9):1477-91. PubMed ID: 25996120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmable Construction of Peptide-Based Materials in Living Subjects: From Modular Design and Morphological Control to Theranostics.
    Li LL; Qiao ZY; Wang L; Wang H
    Adv Mater; 2019 Nov; 31(45):e1804971. PubMed ID: 30450607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications.
    Kim H; Beack S; Han S; Shin M; Lee T; Park Y; Kim KS; Yetisen AK; Yun SH; Kwon W; Hahn SK
    Adv Mater; 2018 Mar; 30(10):. PubMed ID: 29363198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional two-dimensional MXenes as cancer theranostic agents.
    Gao N; Zhao J; Zhu X; Xu J; Ling G; Zhang P
    Acta Biomater; 2022 Dec; 154():1-22. PubMed ID: 36243374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances in Carbon Nanomaterials for Cancer Phototherapy.
    Jiang BP; Zhou B; Lin Z; Liang H; Shen XC
    Chemistry; 2019 Mar; 25(16):3993-4004. PubMed ID: 30328167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescent nanodiamond for nanotheranostic applications.
    Pramanik G; Bag S; Chakrabortty S
    Mikrochim Acta; 2022 Nov; 189(12):447. PubMed ID: 36378347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-Graphene 2D Materials: Structures, Properties, and Cancer Therapy Applications.
    Kuang F; Hui T; Chen Y; Qiu M; Gao X
    Adv Healthc Mater; 2024 Feb; 13(5):e2302604. PubMed ID: 37955406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
    Zhou LQ; Li P; Cui XW; Dietrich CF
    Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
    Sun SK; Wang HF; Yan XP
    Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease-activated nanomaterials for targeted cancer theranostics.
    Chan YC; Hsiao M
    Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical Modification of Chitosan for Developing Cancer Nanotheranostics.
    Li X; Wang Y; Feng C; Chen H; Gao Y
    Biomacromolecules; 2022 Jun; 23(6):2197-2218. PubMed ID: 35522524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responsive Polymer Brush Design and Emerging Applications for Nanotheranostics.
    Li D; Xu L; Wang J; Gautrot JE
    Adv Healthc Mater; 2021 Mar; 10(5):e2000953. PubMed ID: 32893474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2D MXene Nanomaterials for Versatile Biomedical Applications: Current Trends and Future Prospects.
    Lu B; Zhu Z; Ma B; Wang W; Zhu R; Zhang J
    Small; 2021 Nov; 17(46):e2100946. PubMed ID: 34323354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.